The infection of UC-MSCs with oncolytic viruses such as NDV can provide a new therapeutic strategy by combining the homing ability of MSCs towards tumor sites and the increased secretion of factors with anti-tumor activity such as TRAIL from the infected cells. This evidence concerns the gene TNFSF10 and infection.